ArticleJournal of hematology & oncology2025

HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors.

Jiin-Tarng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.